These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21598345)

  • 21. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
    Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
    Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
    Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
    J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases.
    Kondo H; Kanematsu M; Itoh K; Ito K; Maetani Y; Goshima S; Matsuo M; Matsunaga N; Konishi J; Hoshi H; Moriyama N
    Magn Reson Imaging; 2005 Jan; 23(1):89-95. PubMed ID: 15733793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
    Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
    Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
    Kim YK; Lee MW; Lee WJ; Kim SH; Rhim H; Lim JH; Choi D; Kim YS; Jang KM; Lee SJ; Lim HK
    Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions.
    Kim MJ; Kim JH; Choi JY; Park SH; Chung JJ; Kim KW; Mitchell DG
    AJR Am J Roentgenol; 2006 Sep; 187(3):W255-66. PubMed ID: 16928903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal liver lesions: characterization with quantitative analysis of T2 relaxation time in TSE sequence with double echo time.
    Cittadini G; Santacroce E; Giasotto V; Rescinito G
    Radiol Med; 2004 Mar; 107(3):166-73. PubMed ID: 15031682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions.
    Goldberg MA; Hahn PF; Saini S; Cohen MS; Reimer P; Brady TJ; Mueller PR
    AJR Am J Roentgenol; 1993 May; 160(5):1011-7. PubMed ID: 8470568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques.
    Lee SS; Byun JH; Hong HS; Park SH; Won HJ; Shin YM; Lee MG
    J Magn Reson Imaging; 2007 Aug; 26(2):323-30. PubMed ID: 17610287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapidly enhancing hepatic hemangiomas at MRI: distinction from malignancies with T2-weighted images.
    Outwater EK; Ito K; Siegelman E; Martin CE; Bhatia M; Mitchell DG
    J Magn Reson Imaging; 1997; 7(6):1033-9. PubMed ID: 9400846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT.
    Baek CK; Choi JY; Kim KA; Park MS; Lim JS; Chung YE; Kim MJ; Kim KW
    Clin Radiol; 2012 Feb; 67(2):148-56. PubMed ID: 21920517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging.
    Jeong HT; Kim MJ; Park MS; Choi JY; Choi JS; Kim KS; Choi GH; Shin SJ
    J Magn Reson Imaging; 2012 Mar; 35(3):635-43. PubMed ID: 22095933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?
    Haradome H; Grazioli L; Al manea K; Tsunoo M; Motosugi U; Kwee TC; Takaraha T
    J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI.
    Yoshimura N; Saito K; Saguchi T; Funatsu T; Araki Y; Akata S; Tokuuye K
    Magn Reson Imaging; 2013 Jan; 31(1):23-7. PubMed ID: 22884242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.
    Doo KW; Lee CH; Choi JW; Lee J; Kim KA; Park CM
    AJR Am J Roentgenol; 2009 Dec; 193(6):W490-6. PubMed ID: 19933623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.